A case-control study of myelodysplastic syndromes in Belgrade (Serbia Montenegro)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bennett M, Catovsky D, Daniel MT et al (1982) Proposals for the classification of MDS. Br J Haematol 51:189–199
Bjork J, Albin M, Mauritzson N, Stromberg U, Johansson B, Hagmar L (2000) Smoking and myelodysplastic syndromes. Epidemiology 11:285–291
Casagrande G, Michot F (1989) Alcohol-induced bone marrow damage; status before and after a 4-week period of abstinence from alcohol with or without disulfram. A randomized bone marrow study in alcohol-dependent individuals. Blut 59:231–236
Dalamaga M, Petridou E, Cook FE, Trichopoulos D (2002) Risk factors for myelodysplastic syndromes: a case-control study in Greece. Cancer Causes Control 13:603–608
Datta R, Sherman ML, Kufe DW (1990) Regulation of proto-oncogene and tumor necrosis factor gene expression by ethanol in HL-60 myeloid leukemia cells. Blood 76:298–301
Enright H, Miller W (1997) Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymph 24:483–489
Farrow A, Jacobs A, West RR (1989) Myelodysplasia, chemical exposure and other environmental factors. Leukemia 3:33–35
Goldberg H, Lusk E, Moore J, Nowell PC, Besa EC (1990) Survey of exposure to genotoxic agents in primary myelodysplastic syndrome—correlation with chromosome patterns and data in patients without haematological disease. Cancer Res 50:6876–6881
Ido M, Nagata C, Kawakami N et al (1996) A case-control study of myelodysplastic syndromes among Japanese men and women. Leuk Res 20:727–731
Levine EG, Bloomfield CD (1992) Leukemia and myelodysplastic syndromes secondary to drugs, radiation and environmental exposure. Semin Oncol 19:47–84
List AF, Doll DF (1999) The myelodysplastic syndromes. In: Foerster GR, Lukens LJ, Paraskevas F, Greer JP, Rodgers GM (eds) Wintrobe’s clinical hematology. Williams & Willkins, Baltimore, MD, pp 2320–2333
McNeil D (1996) Epidemiological research methods. Wiley, New York
Nagata C, Shimizu H, Hirashima K et al (1999) Hair dye use and occupational exposure to organic solvents as risk factors for myelodysplastic syndrome. Leuk Res 23:57–62
Nisse C, Haguenoer JM, Grandbastein B et al (2001) Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France. Br J Haematol 112:927–935
Obe G, Gobel D, Engeln H, Herha J, Natarajan AT (1980) Chromosomal aberrations in peripheral lymphocytes of alcoholics. Mutat Res 73:229–259
Okamoto T, Okada M, Mori A (1997) Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients. Int J Hematol 66:345–351
Pasqualetti P, Casale R, Burmeister LF et al (1991) Occupational risk for hematological malignancies. Am J Hematol 38:147–152
Pedersen-Bjergaard J (1992) Radiotherapy and chemotherapy induced myelodysplasia and acute myeloid leukaemia. A review. Leuk Res 16:61–65
Rigolin GM, Cuneo A, Roberti MG, Bardi A, Bigoni R, Piva N, Monotto C, Agostini P, De Angeli C, Del Senno L, Spanedda R, Castoldi G (1998) Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings. Br J Haematol 103:189–197
Tavani A, Pregnolato A, Negri E et al (1997) Diet and risk of lymphoid neoplasms and soft tissue sarcomas. Nutr Cancer 27:256–260
Vlajinac H, Pekmezovic T, Adanja B, Marinkovic J, Kanazir M, Suvajdzic N, Colovic M (2003) Case-control study of multiple myeloma with special reference to diet as risk factor. Neoplasma 50:79–83
Vogel VG, Fisher RE (1993) Epidemiology and etiology of leukemia. Curr Opin Oncol 5:26–34
Ward MH, Zahm SH, Weisenburger DD et al (1994) Dietary factors and non-Hodgkin’s lymphoma in Nebraska (United States). Cancer Causes Control 5:422–432